|
|
Pathological Calcification: Cyrstallization, Infection or Cell
Transdifferentiation
Sponsored by The American Federation for
Medical Research
Sun. April 2 — 3:15-5:15 PM
|
| Chaired: |
Virginia M. Miller, Mayo Clin. Col. of Med.
John C. Lieske, Mayo Clin. Col. of Med. |
It is becoming increasingly clear that the pathophysiology of
calcification within diseased human tissues is complex. Inflammation
appears to be associated with many calcific processes including advanced
atherosclerosis, nephrolithiasis, and calciphylaxis of end stage renal
disease. In all three instances characteristic cellular responses could
potentially either mediate or ameliorate the calcific response.
Increasingly, microorganisms are being identified as an unexpected cause
of disease, with a recent well-known example being the association of H.
pylori and peptic ulcer. The possibility that micro-organisms contribute
to pathologic calcification and the associated inflammation is, however,
controversial. This symposium will examine evidence for three possible,
but not mutually exclusive mechanisms of pathologic calcification: (1)
Processes that drive and influence inorganic crystallization; (2)
The mechanisms by which cells mediate crystallization, including cell
transdifferentiation; and (3) Evidence for the presence of calcifying
micro-organisms within diseased human kidneys and arteries. The program
will conclude with a panel discussion led by a moderator who will comment
on divergent points from the perspective of a pathologist.
|
3:15 PM |
Vascular calcification in end stage renal disease.
Neal Chen, Indiana Univ. Sch. of
Medicine
|
|
3:35 PM |
Cell biology of pathologic renal calcification.
John C. Lieske,
Mayo Clin. Col. of Med.
|
|
3:55 PM |
Bone cell phenotypes within blood vessels.
Linda Demer,
UCLA Sch. of Med.
|
|
4:15 PM |
Mechanisms of focal calcification in atherosclerosis.
Howard H. Hsu,
Univ. of Kansas Med. Ctr.
|
|
4:35 PM |
Calcific biofilms: is there a biological x-ray signature?
Karim Benzerera, Stanford Univ.
|
|
4:55 PM |
Nanobacteria: fact or fiction.
Neva Ciftcioglu,
NASA Johnson Space Ctr.
|
|
|